Back
Top 2%
11.8%
Top 53%
11.8%
Top 16%
9.0%
Top 2%
6.4%
Top 3%
6.4%
Top 19%
5.9%
Top 46%
5.9%
Top 2%
5.9%
Top 2%
5.0%
Top 0.5%
4.1%
Top 1%
3.8%
Top 2%
3.8%
Top 3%
1.5%
Top 13%
1.3%
Top 7%
1.3%
Top 16%
0.9%
Top 9%
0.7%
Top 2%
0.7%
Global Distribution and Characteristics of Research Facilities Participating in Phase III Oncology Trials
2026-02-10
oncology
Title + abstract only
View on medRxiv
Show abstract
BackgroundResearch infra-structure is essential for conducting phase III cancer clinical trials as its lack precludes trial availability and its maturity may influence the portfolio of available options. Several studies have highlighted global disparities, but none has ever mapped the worldwide network of research facilities conducting such trials. MethodsWe extracted all research sites within recruiting phase III cancer interventional trials from the ClinicalTrials.gov database on July 23, 202...
Predicted journal destinations
1
Cancers
57 training papers
2
PLOS ONE
1737 training papers
3
BMJ Open
553 training papers
4
Frontiers in Oncology
34 training papers
5
eLife
262 training papers
6
Nature Communications
483 training papers
7
Scientific Reports
701 training papers
8
JAMA Network Open
125 training papers
9
Clinical Cancer Research
22 training papers
10
BMC Cancer
21 training papers
11
Cancer Medicine
17 training papers
12
British Journal of Cancer
22 training papers
13
BMC Health Services Research
43 training papers
14
BMJ Global Health
95 training papers
15
Nature Medicine
88 training papers
16
Proceedings of the National Academy of Sciences
100 training papers
17
PeerJ
46 training papers
18
International Journal of Cancer
18 training papers